|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Thursday, January 31
Does the RT3 accelerometer spell the end of pen-and-paper questionnaires?
by
multiplesclerosis
on Thu 31 Jan 2008 02:00 AM CST
Here is a great thought…the arduous task of filling out boring questionnaires may soon be obsolete! Well, at least for people with multiple sclerosis (MS) whose activity levels must be monitored by doctors. Thanks to more »
Wednesday, January 30
Hygiene hypothesis: Innate immunity, malaria and multiple sclerosis
by
multiplesclerosis
on Wed 30 Jan 2008 10:13 AM CST
Hygiene hypothesis: Innate immunity, malaria and multiple sclerosis Institute of Clinical Neurology, University of Sassari, Viale San Pietro, 10, 07100 Sassari, Italy
Institute of ... more »
Tuesday, January 29
Evaluation of Clinical Course Of Progressive MS In Brazilian Patients
by
multiplesclerosis
on Tue 29 Jan 2008 07:07 AM CST
New research indicates that the clinical course of progressive multiple sclerosis among Brazilian patients is comparable to the clinical course
Previous studies have suggested that MS is more likely to occur in cold-weather areas such as northern Europe and the northern United States. To assess the clinical course and outcomes of progressive MS in the warm-weather country of Brazil, researchers utilized the more »
Successful Thorough QT Study of Fampridine-SR
by
multiplesclerosis
on Tue 29 Jan 2008 05:00 AM CST
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced results from a thorough QT study of Fampridine-SR. This study evaluated the potential to cause an increase in the more »
Monday, January 28
Smoking Has No Effect on Progression of Multiple Sclerosis
by
multiplesclerosis
on Mon 28 Jan 2008 02:00 AM CST
Smoking Has No Effect on Progression of Multiple Sclerosis ST. PAUL, MN , USA–
Contrary to an earlier report, smoking appears ... more » Sunday, January 27
Antibody leads to repair of myelin sheath in lab study of MS
by
multiplesclerosis
on Sun 27 Jan 2008 03:00 AM CST
Mayo Clinic researchers have found that a human antibody administered in a single low dose in laboratory mouse models can repair more »
Saturday, January 26
Pregnancy and the Postpartum Period on MS
by
multiplesclerosis
on Sat 26 Jan 2008 08:44 AM CST
During pregnancy, relapsing remitting multiple sclerosis (MS) has no distinct unfavourable effects on pregnancy, labour and delivery, according to more »
Friday, January 25
New therapeutic target for the treatment of multiple sclerosis
by
multiplesclerosis
on Fri 25 Jan 2008 07:42 AM CST
A study published in the February issue of Nature Immunology provides answers about the role of novel adhesion molecules in the pathogenesis of multiple sclerosis (MS) and suggests more »
Thursday, January 24
No Differences Found Between Betaseron and Copasone for MS
by
multiplesclerosis
on Thu 24 Jan 2008 01:00 AM CST
No Differences Found Between Interferon Beta-1b and Glatiramer for Multiple Sclerosis:
Presented at ECTRIMS
Treatment with interferon beta-1b (IFNbeta-1b) ... more » Tuesday, January 22
Three Genomic Markers Correlate With Multiple Sclerosis:
by
multiplesclerosis
on Tue 22 Jan 2008 08:51 AM CST
Three Genomic Markers Correlate With Multiple Sclerosis: Three gene variants have been found to correlate with susceptibility to multiple sclerosis, according to findings of ... more » Monday, January 21
Trial – for efficacy and safety of FTY720
by
multiplesclerosis
on Mon 21 Jan 2008 12:00 AM CST
Trial – for efficacy and safety of FTY720Trial InformationSummary: A 24-month, double-blind, randomized, multi-center, placebo-controlled, parallel-group study comparing the efficacy and safety ... more »Saturday, January 19
Oral Fampridine-SR on Walking Ability in Multiple Sclerosis
by
multiplesclerosis
on Sat 19 Jan 2008 10:13 AM CST
Sponsored by: Acorda Therapeutics Information provided by: Acorda Therapeutics ClinicalTrials.gov ... more »
Trial for MS patients with Cognitive Impairment
by
multiplesclerosis
on Sat 19 Jan 2008 12:00 AM CST
Trial for MS patients with Cognitive ImpairmentTrial InformationSummary: A Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study to Assess the Safety, Efficacy and Tolerability ... more »Friday, January 18
Trial – Fampridine-SR (can it improve walking ability and muscle strength in MS?)
by
multiplesclerosis
on Fri 18 Jan 2008 08:42 AM CST
Trial – Fampridine-SR (can it improve walking ability and muscle strength in MS?)Trial InformationSummary: A 21 WEEK STUDY TO EVALUATE SAFETY AND ... more »
Rebif-New Formulation Drug Trial for RRMS
by
multiplesclerosis
on Fri 18 Jan 2008 08:17 AM CST
Rebif-New Formulation Drug Trial for RRMSTrial InformationSummary: Quality of Life study for patients with relapsing forms of Multiple Sclerosis who are transitioning ... more » |
||
